The cost-effectiveness of particle therapy in non-small cell lung cancer: Exploring decision uncertainty and areas for future research
- 19 March 2010
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 36 (6), 468-476
- https://doi.org/10.1016/j.ctrv.2010.02.018
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysisRadiotherapy and Oncology, 2009
- American Society of Clinical Oncology Guidance Statement: The Cost of Cancer CareJournal of Clinical Oncology, 2009
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular TrendsJournal of Thoracic Oncology, 2008
- Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methodsClinical Trials, 2008
- Carbon Ion Radiotherapy for Stage I Non-small Cell Lung Cancer Using a Regimen of Four Fractions during 1 WeekJournal of Thoracic Oncology, 2007
- PD4-1-6: Acute esophageal reactions from proton beam therapy and concurrent chemotherapy for non-small cell lung cancer (NSCLS): Reduction in incidence and severity despite higher dosesJournal of Thoracic Oncology, 2007
- A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between CountriesPharmacoEconomics, 2004
- An economic approach to clinical trial design and research priority-settingHealth Economics, 1996
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990